Aspartate Aminotransferases
"Aspartate Aminotransferases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1.
Descriptor ID |
D001219
|
MeSH Number(s) |
D08.811.913.477.700.225
|
Concept/Terms |
Aspartate Aminotransferases- Aspartate Aminotransferases
- Aminotransferases, Aspartate
- Aspartate Apoaminotransferase
- Apoaminotransferase, Aspartate
- Aspartate Transaminase
- Transaminase, Aspartate
- Glutamic-Oxaloacetic Transaminase
- Glutamic Oxaloacetic Transaminase
- Transaminase, Glutamic-Oxaloacetic
- L-Aspartate-2-Oxoglutarate Aminotransferase
- Aminotransferase, L-Aspartate-2-Oxoglutarate
- L Aspartate 2 Oxoglutarate Aminotransferase
- Aspartate Aminotransferase
- Aminotransferase, Aspartate
- Glutamate-Aspartate Transaminase
- Glutamate Aspartate Transaminase
- Transaminase, Glutamate-Aspartate
SGOT- SGOT
- Serum Glutamic-Oxaloacetic Transaminase
- Glutamic-Oxaloacetic Transaminase, Serum
- Serum Glutamic Oxaloacetic Transaminase
- Transaminase, Serum Glutamic-Oxaloacetic
|
Below are MeSH descriptors whose meaning is more general than "Aspartate Aminotransferases".
Below are MeSH descriptors whose meaning is more specific than "Aspartate Aminotransferases".
This graph shows the total number of publications written about "Aspartate Aminotransferases" by people in this website by year, and whether "Aspartate Aminotransferases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 1 | 2 |
1995 | 0 | 2 | 2 |
1996 | 0 | 3 | 3 |
1999 | 0 | 1 | 1 |
2000 | 0 | 2 | 2 |
2002 | 0 | 2 | 2 |
2003 | 0 | 4 | 4 |
2004 | 0 | 1 | 1 |
2005 | 0 | 2 | 2 |
2006 | 1 | 2 | 3 |
2007 | 0 | 3 | 3 |
2008 | 0 | 2 | 2 |
2009 | 0 | 2 | 2 |
2010 | 1 | 1 | 2 |
2011 | 0 | 3 | 3 |
2012 | 2 | 4 | 6 |
2013 | 0 | 3 | 3 |
2014 | 3 | 4 | 7 |
2015 | 1 | 1 | 2 |
2016 | 0 | 6 | 6 |
2017 | 0 | 2 | 2 |
2018 | 1 | 2 | 3 |
2019 | 2 | 1 | 3 |
2020 | 1 | 8 | 9 |
2021 | 0 | 2 | 2 |
2022 | 0 | 3 | 3 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aspartate Aminotransferases" by people in Profiles.
-
Risk factors for more rapid progression of severe liver fibrosis in children with cystic fibrosis-related liver disease: A multi-center study validated by liver biopsy. Liver Int. 2023 06; 43(6):1277-1286.
-
Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial. Lancet Oncol. 2022 10; 23(10):1261-1273.
-
Combining FIB-4 and Liver Stiffness Into the FIB-5, a Single Model that Accurately Predicts Complications of Portal Hypertension. Am J Gastroenterol. 2022 12 01; 117(12):1999-2008.
-
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial. Lancet Gastroenterol Hepatol. 2022 03; 7(3):208-218.
-
Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational Study. Hepatology. 2021 10; 74(4):2047-2057.
-
Current and Past Infections of HBV Do Not Increase Mortality in Patients With COVID-19. Hepatology. 2021 10; 74(4):1750-1765.
-
Brief Report: Accuracy of FIB-4 for Cirrhosis in People Living With HIV and Hepatocellular Carcinoma. J Acquir Immune Defic Syndr. 2020 12 15; 85(5):530-534.
-
Fish Oil Emulsion Reduces Liver Injury and Liver Transplantation in Children with Intestinal Failure-Associated Liver Disease: A Multicenter Integrated Study. J Pediatr. 2021 03; 230:46-54.e2.
-
Case series and review of liver dysfunction in COVID-19 patients. Eur J Gastroenterol Hepatol. 2020 09; 32(9):1244-1250.
-
Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice. Gastroenterology. 2020 11; 159(5):1731-1751.e10.